Vaijayanti P Kale

Title: Vaijayanti P Kale: Innovator in Hematopoietic Stem Cell Preservation

Introduction

Vaijayanti P Kale is a notable inventor based in Pune, India. She has made significant contributions to the field of clinical hematology, particularly in the preservation of human hematopoietic stem or progenitor cells. Her innovative approach has the potential to enhance the effectiveness of stem cell therapies.

Latest Patents

Vaijayanti P Kale holds a patent for a method focused on the preservation of human hematopoietic stem or progenitor cells. This method emphasizes the maintenance of quiescent hematopoietic stem and progenitor cells (HSPC) in culture without the addition of exogenous growth factors. Her research highlights the effectiveness of Flt3 receptor-interacting lectin (FRIL) in maintaining cord blood-derived progenitors in vitro. The study examined four mannose-binding lectins and assessed their HSPC preservation activity through in vitro colony forming unit (CFU) and long-term culture initiating cell (LTC-IC) assays. The findings revealed that all four lectins maintained HSPC preservation activity for at least 30 days in culture without the need for additional growth factors. This innovative approach suggests a cost-effective method for HSPC maintenance in clinical applications.

Career Highlights

Vaijayanti P Kale has worked with esteemed institutions such as the Department of Biotechnology and the Indian Institute of Science. Her work has been instrumental in advancing research in hematopoietic stem cell preservation.

Collaborations

Some of her notable coworkers include Lalita S Limaye and Ashwini Hinge. Their collaborative efforts have contributed to the success of her research initiatives.

Conclusion

Vaijayanti P Kale's contributions to the field of hematopoietic stem cell preservation demonstrate her innovative spirit and dedication to advancing clinical hematology. Her work has the potential to significantly impact stem cell therapies and improve patient outcomes.